Emergent BioSolutions Inc. (EBS) - Total pendapatan perusahaan

Emergent BioSolutions leads the development of innovative drug delivery systems and infection therapies. Tracking the company's sales confirms this trajectory, where 0.65 reflects the latest metric level. Its status as the exclusive supplier of antidotes for government defense provides the firm with significant pricing power. Meanwhile, revenues balance between stable demand for Narcan and the strict limits of US government budgets.

Pendapatan lan volume dodolan: Emergent BioSolutions Inc. (EBS) kanggo 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis Emergent BioSolutions Inc. (EBS)

- nilai pasar lan prakiraan target analis:

Bagan bursa Emergent Bio|EBS - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Nilai pasar Emergent BioSolutions Inc.|EBS - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Nilai Akuntansi saben Saham Emergent BioSolutions|EBS - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku emergentbiosolutions.com|EBS - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Emergent BioSolutions|EBS - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Emergent BioSolutions Inc|EBS - Gunggung utang perusahaan|Utang-utang marang nilai buku Emergent BioSolutions Inc.|EBS - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Emergent BioSolutions|Rasio likuiditas perantara emergentbiosolutions.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

EBS - Penghasilan resik|Penghasilan resik sing dikarepake Emergent BioSolutions|EBS - Pangali P/E|Rega marang bathi mangsa ngarep emergentbiosolutions.com|EBS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Emergent BioSolutions Inc.|EBS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Emergent BioSolutions|EBS - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan emergentbiosolutions.com|EBS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Emergent BioSolutions

- statistik dodolan lan pendapatan perusahaan:

EBS - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Emergent Bio|EBS - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Emergent BioSolutions Inc.

Ringkesan analisis perusahaan:EBS (Emergent Bio)

Barang unggulan Emergent BioSolutions Inc.

Professional capital evaluates the profile of Emergent BioSolutions (EBS) through the lens of cash flow stability. The company's overall sales figures reflect daily market equilibrium, where steady growth confirms demand, while sharp spikes signal the risk of market saturation. This metric measures the operational efficiency of product realization. For Emergent BioSolutions (EBS), the stability of the curve is driven by long-term US government contracts, confirming the high reliability of the asset.

Analisis perusahaan pesaing